Basic Information
Fortacin
Regulatory Information
EMEA/H/C/002693
Authorised
November 15, 2013
September 19, 2013
13
February 3, 2025
Company Information
Ireland
Raheens East Ringaskiddy, Co. Cork,
Recordati Ireland Ltd.
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of primary premature ejaculation in adult men.
Overview Summary
Fortacin is used to treat men with primary (lifelong) premature ejaculation (when ejaculation regularly occurs before, or too early during, penetration). Fortacin contains the active substances lidocaine and prilocaine.